Morgan Stanley Maintains Overweight on Alumis, Lowers Price Target to $29

Benzinga Newsdesk www.benzinga.com Negative 83.5%

Neg 83.5% Neu 0% Pos 0%

Morgan Stanley analyst Terence Flynn maintains Alumis (NASDAQ:ALMS) with a Overweight and lowers the price target from $39 to $29.